Enloe Health has introduced a new heart procedure, the Left Atrial Appendage Closure (LAAC) surgery, or the "Watchman ...

One of the standout products in Boston Scientific's portfolio is the Watchman FLX Left Atrial Appendage Closure (LAAC) device. Recent clinical trial results from the OPTION study demonstrated ...

It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices ...

My doctor told me about the OPTION clinical trial and suggested that I consider a WATCHMAN device. Can you comment on OPTION, for which results were published recently? I’ve read that about 90% ...

A Watchman is a device that can help prevent blood clots from leaving the heart. However, the procedure to insert the device carries its risks, including cardiac tamponade and ischemic stroke.

My doctor told me about the OPTION clinical trial and suggested that I consider a Watchman device. Can you comment on OPTION, for which results were published recently? I've read that about 90% of ...

Van ECK Associates Corp cut its stake in Lithium Americas (Argentina) Corp. (NYSE:LAAC – Free Report) by 3.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,934,634 shares ...